VER­TEX Vows To moVE fasT on nEw DRUG DEaL

Daily Express - - News -

THE boss of US phar­ma­ceu­ti­cal gi­ant Ver­tex has writ­ten to the Daily Ex­press to stress its com­mit­ment to agree­ing a deal for its up­com­ing Trikafta drug.

Con­cerned John Binns, 71, had writ­ten to Ver­tex’s Dr Jeff Lei­den to thank him af­ter his cys­tic fi­bro­sis-suf­fer­ing grand­son Tris­tan Scott-Binns, nine, fi­nally got Orkambi.

The lad is be­ing raised by his grand­par­ents af­ter his dad An­drew died af­ter suf­fer­ing de­pres­sion and his un­cle Adam, 25, died from CF.

This week, Dr Lei­den replied to us, say­ing: “We are com­mit­ted to en­sur­ing peo­ple liv­ing with CF in the UK have ac­cess to our medicines. We are work­ing with a sense of ur­gency to make it hap­pens as soon as pos­si­ble.”

Ver­tex’s cur­rent CF drugs Orkambi and Symkevi are suit­able for 50 per cent of pa­tients but Trikafta is bet­ter and suit­able for 90 per cent of CF-ers.

The Euro­pean Medicines Agency is pro­cess­ing its li­cence for Trikafta. Dr Lei­den added: “We will do all we can to move quickly and be col­lab­o­ra­tive with NHS England and NICE.”

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.